There is an urgent need for effective vaccines against serogroup B Neisseri
a Meningitidis. Current experimental vaccines based on the outer membrane p
roteins (OMPs) of this organism provide a measure of protection in older ch
ildren but have been ineffective in infants. We postulated that the inabili
ty of OMP vaccines to protect infants might be due to age-dependent defects
in cellular immunity, We measured proliferation and in vitro production of
gamma interferon (IFN-gamma), tumor necrosis factor alpha, and interleukin
-10 (IL-10) in response to meningococcal antigens by peripheral blood monon
uclear cells (PBMCs) from children convalescing from meningococcal disease
and from controls. After meningococcal infection, the balance of cytokine p
roduction by PBMCs from the youngest children was skewed towards a T(H)1 re
sponse (low IL-10/ IFN-gamma ratio), while older children produced more T(H
)2 cytokine (higher IL-10/IFN-gamma ratio). There was a trend to higher pro
liferative responses by PBMCs from older children. These responses,were not
influenced by the presence or subtype of class 1 (PorA) OMP or by the pres
ence of class 2/3 (PorB) or class 4 OMP, Even young infants might be expect
ed to develop adequate cellular immune responses to serogroup B N. meningit
idis vaccines if a vaccine preparation can be formulated to mimic the immun
e stimulus of invasive disease, which may include stimulation of T(H)2 cyto
kine production.